Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

C33H30N4O2

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

164 API Suppliers, 42 USDMF, 43 CEP/COS, 18 JDMF, 19 EU WC, 49 KDMF, 20 NDC API, 78 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

136 Drugs in Development

136 Drugs in Development

INTERMEDIATES

54 Intermediate Suppliers

54 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1142 FDF Dossiers, 113 FDA Orange Book, 552 Europe, 61 Canada, 88 Australia, 81 South Africa, 247 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;80MG, TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 19 SPI Pharma, 4 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 14 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 44 Disintegrants & Superdisintegrants, 41 Direct Compression, 40 Coating Systems & Additives, 31 Granulation, 22 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 19 Taste Masking, 18 Controlled & Modified Release, 18 Thickeners and Stabilizers, 14 Co-Processed Excipients, 14 Film Formers & Plasticizers, 11 Solubilizers, 9 Parenteral, 5 Emulsifying Agents, 5 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

46 News #PharmaBuzz

46 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 US Medicaid Prescriptions, 191 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

35 APIs, 12 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 Health Canada Patents

28 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 18 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Interquim SA	Spain	Interquim, S.A. Sant Cugat Del Vallès ES	R1-CEP 2010-363 - Rev 00	Telmisartan	2019-02-04	Valid	Chemical		2154
29/11/2025	ACG Worldwide	India	AGC PHARMA CHEMICALS EUROPE S.L.U. Malgrat De Mar ES	R1-CEP 2009-054 - Rev 03	Telmisartan	2019-12-03	Valid	Chemical		2154

C33H30N4O2

C33H30N4O2

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

164 API Suppliers

42 USDMF

43 CEP/COS

18 JDMF

19 EU WC

49 KDMF

20 NDC API

78 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

136 Drugs in Development

INTERMEDIATES

54 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1142 FDF Dossiers

113 FDA Orange Book

552 Europe

61 Canada

88 Australia

81 South Africa

247 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG

TABLET;ORAL - 40MG

TABLET;ORAL - 80MG

TABLET;ORAL - 12.5MG;40MG

TABLET;ORAL - 12.5MG;80MG

TABLET;ORAL - 25MG;80MG

TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Rochem International Inc

19 SPI Pharma

4 DKSH

8 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 ACG Worldwide

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

14 BASF

1 CD Formulation

10 Corel Pharma Chem

7 DFE Pharma

8 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

3 Nitika Pharmaceutical Specialities

3 Novo Excipients

5 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

29 Roquette

7 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

TABLET;ORAL - EQ 10MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 10MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons